Insurance Challenges and Costs Many private insurers are denying coverage for anti-obesity medications, creating a significant obstacle in treatment accessibility
In our lifetime, we have seen processes go from primitive dental drills to advanced dental implants and more
Ozempic and stomach paralysis The UBC research is the first epidemiological study that links popular weight loss drugs to stomach paralysis and other serious gastrointestinal conditions
How Long Does it Take to See Results with Semaglutide
The effect of tirzepatide on 24-hour mean systolic BP, diastolic BP, and heart rate (HR) measured during 24-hour ambulatory BP monitoring (ABPM) in individuals living with obesity without T2DM, has been evaluated in the SURMOUNT-1 ABPM sub-study.34 After 36 weeks of treatment, tirzepatide was associated with statistically significant and clinically meaningful reductions in the mean 24-hour systolic BP at all doses and reduced diastolic BP at the 2 lower doses.34 Simultaneously, tirzepatide treatment was associated with a dose-dependent increase in the mean 24-hour HR.34 Fortunately, there is no clear evidence that tirzepatide increases the risk of atrial fibrillation.35 5
To meet demand, both Lilly and Novo look to expand supply capacity of their GLP-1 portfolios
